These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 22072239)
41. Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis. Xiao Y; Wang L; Jiang X; She W; He L; Hu G Nucl Med Commun; 2016 Nov; 37(11):1180-8. PubMed ID: 27428888 [TBL] [Abstract][Full Text] [Related]
42. Diagnostic Value of (18)F-FDG PET/CT in Detecting Local Recurrent Colorectal Cancer: A Pooled Analysis of 26 Individual Studies. Yu T; Meng N; Chi D; Zhao Y; Wang K; Luo Y Cell Biochem Biophys; 2015 Jun; 72(2):443-51. PubMed ID: 25737131 [TBL] [Abstract][Full Text] [Related]
43. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Gould MK; Kuschner WG; Rydzak CE; Maclean CC; Demas AN; Shigemitsu H; Chan JK; Owens DK Ann Intern Med; 2003 Dec; 139(11):879-92. PubMed ID: 14644890 [TBL] [Abstract][Full Text] [Related]
44. 18 F-fluorodeoxyglucose positron emission tomography to evaluate recurrent gastric cancer: a systematic review and meta-analysis. Wu LM; Hu JN; Hua J; Gu HY; Zhu J; Xu JR J Gastroenterol Hepatol; 2012 Mar; 27(3):472-80. PubMed ID: 21916986 [TBL] [Abstract][Full Text] [Related]
45. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis. Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513 [TBL] [Abstract][Full Text] [Related]
46. A meta-analysis on the diagnostic performance of (18)F-FDG and (11)C-methionine PET for differentiating brain tumors. Zhao C; Zhang Y; Wang J AJNR Am J Neuroradiol; 2014 Jun; 35(6):1058-65. PubMed ID: 24029389 [TBL] [Abstract][Full Text] [Related]
47. FDG PET/CT for the detection of bone marrow involvement in diffuse large B-cell lymphoma: systematic review and meta-analysis. Adams HJ; Kwee TC; de Keizer B; Fijnheer R; de Klerk JM; Nievelstein RA Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):565-74. PubMed ID: 24281821 [TBL] [Abstract][Full Text] [Related]
48. Clinical and Prognostic Role of 18F-FDG PET/CT in Pediatric Ewing Sarcoma. Albano D; Dondi F; Schumacher RF; D'Ippolito C; Porta F; Giubbini R; Bertagna F J Pediatr Hematol Oncol; 2020 Mar; 42(2):e79-e86. PubMed ID: 31135716 [TBL] [Abstract][Full Text] [Related]
49. Meta-analysis of diagnosis of liver metastatic cancers: comparison of (18) FDG PET-CT and gadolinium-enhanced MRI. Deng J; Tang J; Shen N J Med Imaging Radiat Oncol; 2014 Oct; 58(5):532-7. PubMed ID: 25208683 [TBL] [Abstract][Full Text] [Related]
50. Diagnostic accuracy of 18F-FDG-PET in patients with testicular cancer: a meta-analysis. Zhao JY; Ma XL; Li YY; Zhang BL; Li MM; Ma XL; Liu L Asian Pac J Cancer Prev; 2014; 15(8):3525-31. PubMed ID: 24870751 [TBL] [Abstract][Full Text] [Related]
51. Direct comparison of diagnostic accuracies of F-18 FDG PET and MRI for detection of bone marrow involvement in lymphoma patients; A meta-analysis. Kim K; Kim SJ Leuk Res; 2020 Dec; 99():106475. PubMed ID: 33189988 [TBL] [Abstract][Full Text] [Related]
52. The diagnostic performance of CT versus FDG PET-CT for the detection of recurrent pancreatic cancer: a systematic review and meta-analysis. Daamen LA; Groot VP; Goense L; Wessels FJ; Borel Rinkes IH; Intven MPW; van Santvoort HC; Molenaar IQ Eur J Radiol; 2018 Sep; 106():128-136. PubMed ID: 30150034 [TBL] [Abstract][Full Text] [Related]
53. (18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis. Xu GZ; Guan DJ; He ZY Oral Oncol; 2011 Jul; 47(7):560-5. PubMed ID: 21621450 [TBL] [Abstract][Full Text] [Related]
54. Diagnostic performance of 18F-FDG PET/CT in patients with fever of unknown origin: a meta-analysis. Hao R; Yuan L; Kan Y; Li C; Yang J Nucl Med Commun; 2013 Jul; 34(7):682-8. PubMed ID: 23636293 [TBL] [Abstract][Full Text] [Related]
55. Post-treatment FDG PET/CT predicts progression-free survival in young patients with small round blue cell tumors: Ewing sarcoma and PNET. Sobic Saranovic DP; Nikitovic M; Saponjski J; Grozdic Milojevic I; Paripovic L; Saranovic D; Beatovic S; Artiko VM Eur J Radiol; 2020 Aug; 129():109076. PubMed ID: 32446127 [TBL] [Abstract][Full Text] [Related]
56. Can Du B; Wang S; Cui Y; Liu G; Li X; Li Y BMJ Open; 2021 Jun; 11(6):e044313. PubMed ID: 34103313 [TBL] [Abstract][Full Text] [Related]
57. Indirect comparison of the diagnostic performance of Hu X; Li D; Liang Z; Liao Y; Yang L; Wang R; Wang P; Cai J BMC Cancer; 2021 Oct; 21(1):1080. PubMed ID: 34615498 [TBL] [Abstract][Full Text] [Related]
58. The value of Ten Hove D; Treglia G; Slart RHJA; Damman K; Wouthuyzen-Bakker M; Postma DF; Gheysens O; Borra RJH; Mecozzi G; van Geel PP; Sinha B; Glaudemans AWJM Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):241-253. PubMed ID: 32594196 [TBL] [Abstract][Full Text] [Related]
59. Accuracy of whole-body FDG-PET and FDG-PET/CT in M staging of nasopharyngeal carcinoma: a systematic review and meta-analysis. Chang MC; Chen JH; Liang JA; Yang KT; Cheng KY; Kao CH Eur J Radiol; 2013 Feb; 82(2):366-73. PubMed ID: 23083522 [TBL] [Abstract][Full Text] [Related]
60. 18F-FDG PET/CT compared to conventional imaging modalities in pediatric primary bone tumors. London K; Stege C; Cross S; Onikul E; Graf N; Kaspers G; Dalla-Pozza L; Howman-Giles R Pediatr Radiol; 2012 Apr; 42(4):418-30. PubMed ID: 22134535 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]